A fibre-optic cancer-detecting probe that is said to improve clinical outcomes for patients has entered clinical trials thanks to assistance from Flinders biomedical engineers and state government funding. [ + ]

Coronary artery disease (CAD) is one of the leading causes of death in modern humans and researchers from the University of Melbourne can now explain why. [ + ]

Manufacturing companies in Australia are finding niches in the medical technologies sector as their traditional markets of mining and automotive diminish. [ + ]

Since 2013, nearly 800 people have contracted avian influenza, mostly from poultry markets, but the infection has ended there as it is unable to spread from person to person. [ + ]

A major release of reference genomes is expected to pave the way for future health, biotechnology and agricultural products. [ + ]

A collaborative study by local scientists has potentially developed a new way to treat one of the most difficult forms of breast cancer. [ + ]

Leading international and local scientific experts will provide insights on current concepts and strategies to deliver the timely diagnostic services required for clinical management. [ + ]

Cost-competitiveness, high-quality data and fast study start-up times are some of the key factors that make Australia an attractive market for clinical trials. But as other countries strive to improve their clinical competitiveness, can Australia hold a dominant position? [ + ]

Researchers are one step closer to a treatment that could 'turn off' the immune response that causes common allergies, including asthma — which affects over two million Australians. [ + ]

Obtaining a patent for a biotech invention is crucial to its further development and eventual commercialisation. Whether it's a new drug, insecticide or diagnostic, the developer needs to know they will have exclusive ownership of the invention and enjoy a return on their usually significant investment when they take the invention to the market. [ + ]

The president of the Australian Society for Microbiology, ASN Conference organisers and the organising committee would like to invite you to stunning Tasmania for the 45th Annual Scientific Meeting and Trade Exhibition. The event will be held in Tasmania's capital city, Hobart, from 2–5 July. [ + ]

Monash University researchers have uncovered how a group of proteins perform like a 'dimmer switch', causing inflammation ranging from acute to chronic. The findings could contribute to new treatments for inflammatory diseases including type 2 diabetes, atherosclerosis, heart attack and stroke.

The National Health and Medical Research Council has restructured its grant program following a major review. [ + ]

Professor Philip Hugenholtz is a microbiologist with a particular interest in 'microbial dark matter' — the vast majority of microorganisms that have not be grown on an agar plate. [ + ]

The World Health Organization recently issued a warning about the need to urgently develop new antibiotics to counter the growing threat of 'superbugs'. [ + ]